FAIM
EXAS

Financial Advocates Investment Management’s Exact Sciences EXAS Stock Holding History

Financial Advocates Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,206
Closed -$292K – 793
2022
Q3 		$292K Buy
+8,206
New +$338K 0.02% 549

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Financial Advocates Investment Management's EXAS Position: Q4 2022 in Review

Financial Advocates Investment Management sold out of Exact Sciences (EXAS) in Q4 2022, closing a stake of 8,206 shares — an estimated $292K sold.

Financial Advocates Investment Management first reported a position in EXAS in Q3 2022 and held it in 1 quarter. The position peaked at $292K in Q3 2022. 552 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

  • Financial Advocates Investment Management reported no remaining Exact Sciences position as of Q4 2022 after selling out during the quarter.
  • Financial Advocates Investment Management sold 8,206 Exact Sciences shares in Q4 2022, an estimated $292K.
  • Financial Advocates Investment Management first reported a position in Exact Sciences in Q3 2022 and held it in 1 quarter.
  • Financial Advocates Investment Management's Exact Sciences position peaked at $292K in Q3 2022.
  • 552 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Financial Advocates Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.